272 related articles for article (PubMed ID: 27291068)
1. Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.
Fujimura T; Kakizaki A; Furudate S; Kambayashi Y; Aiba S
J Dermatol Sci; 2016 Sep; 83(3):167-73. PubMed ID: 27291068
[TBL] [Abstract][Full Text] [Related]
2. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T; Aiba S
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.
Fujimura T; Kambayashi Y; Fujisawa Y; Hidaka T; Aiba S
Front Oncol; 2018; 8():3. PubMed ID: 29410946
[TBL] [Abstract][Full Text] [Related]
4. Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors.
Massi D; Marconi C; Franchi A; Bianchini F; Paglierani M; Ketabchi S; Miracco C; Santucci M; Calorini L
Hum Pathol; 2007 Oct; 38(10):1516-25. PubMed ID: 17640716
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma.
Furudate S; Fujimura T; Kakizaki A; Hidaka T; Asano M; Aiba S
J Dermatol Sci; 2016 Sep; 83(3):182-9. PubMed ID: 27342040
[TBL] [Abstract][Full Text] [Related]
6. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response.
Ong SM; Tan YC; Beretta O; Jiang D; Yeap WH; Tai JJ; Wong WC; Yang H; Schwarz H; Lim KH; Koh PK; Ling KL; Wong SC
Eur J Immunol; 2012 Jan; 42(1):89-100. PubMed ID: 22009685
[TBL] [Abstract][Full Text] [Related]
7. M1 and M2 macrophages' clinicopathological significance in cutaneous melanoma.
Falleni M; Savi F; Tosi D; Agape E; Cerri A; Moneghini L; Bulfamante GP
Melanoma Res; 2017 Jun; 27(3):200-210. PubMed ID: 28272106
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
[TBL] [Abstract][Full Text] [Related]
9. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
10. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
[TBL] [Abstract][Full Text] [Related]
11. Activation of mesenchymal stem cells by macrophages promotes tumor progression through immune suppressive effects.
Jia XH; Feng GW; Wang ZL; Du Y; Shen C; Hui H; Peng D; Li ZJ; Kong DL; Tian J
Oncotarget; 2016 Apr; 7(15):20934-44. PubMed ID: 26988913
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor associated macrophages (TAMs) via nanocarriers.
Singh Y; Pawar VK; Meher JG; Raval K; Kumar A; Shrivastava R; Bhadauria S; Chourasia MK
J Control Release; 2017 May; 254():92-106. PubMed ID: 28377038
[TBL] [Abstract][Full Text] [Related]
13. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
14. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
15. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella V; Castillo J; Tarazona N; Gimeno-Valiente F; Martínez-Ciarpaglini C; Cabeza-Segura M; Roselló S; Roda D; Huerta M; Cervantes A; Fleitas T
Cancer Treat Rev; 2020 Jun; 86():102015. PubMed ID: 32248000
[TBL] [Abstract][Full Text] [Related]
17. The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.
Furudate S; Fujimura T; Kakizaki A; Kambayashi Y; Asano M; Watabe A; Aiba S
Exp Dermatol; 2016 Feb; 25(2):107-12. PubMed ID: 26441016
[TBL] [Abstract][Full Text] [Related]
18. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
20. Cognate Interaction With CD4
Eisel D; Das K; Dickes E; König R; Osen W; Eichmüller SB
Front Immunol; 2019; 10():219. PubMed ID: 30853959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
